whereas the limited research that has been conducted on postoperative complications has focused on epilepsy-specific neurosurgical procedures, such as anterior temporal lobectomy. 8 The current study sought to delineate the postoperative complications, length of stay (LOS), and discharge disposition differences among surgical patients with epilepsy following shoulder arthroplasty in a large cohort of individuals admitted to hospitals in the United States.
Materials and Methods
Encounter data for this retrospective cross-sectional analysis were extracted from the National Inpatient Sample (NIS) for 2002 through 2011. Sponsored by the Agency for Healthcare Research and Quality (AHRQ), the NIS is a survey of more than 1000 short-term and non-federal hospitals conducted annually. Published since 1988, this survey has been updated yearly to include demographic, clinical, and resource-use data. 9 The yearly survey consists of a 20% random sample of all hospital discharges from selected hospitals in participating states. 10 The NIS is the largest publicly available all-payer inpatient discharge database in the United States. 11, 12 A dynamic health care tool, this database records up to 25 medical diagnoses (15 before the year 2009) and 15 procedures, which can be identified through International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Most notably, the database includes patient and provider characteristics and hospitalization-related information such as LOS and discharge destination. A review of current literature reveals that databases such as NIS have been used to analyze pertinent medical questions. 10, [13] [14] [15] This study was exempt from approval by the authors' institutional review board because all data used were deidentified before use and commercially available.
Identification of Sample and Definitions
The authors considered all discharges with a primary procedure code (ICD-9-CM) for total shoulder arthroplasty (81.80, 81.88) or hemiarthroplasty (81.81). To illustrate the association of epilepsy with in-hospital complications and prolonged LOS after shoulder arthroplasty, this cohort was subdivided into those who were classified as having a diagnosis of epilepsy (345.0x-345.5x and 345.7x-345.9x) and those who did not. 16 Demographic variables were age, sex, race/ethnicity (White, Black, Hispanic, other, unknown), and primary health insurance (Medicare, Medicaid, private, other). Based on available literature and clinical likelihood, [3] [4] [5] 16, 17 several comorbidities were selected that could act as confounders in the relationship between epilepsy and patient outcomes after shoulder arthroplasty: congestive heart failure, chronic lung disease, liver disease, renal failure, peripheral vascular disease, diabetes mellitus, depression, psychosis, and alcohol or substance abuse. To further reduce confounding variables, several primary diagnoses were selected that could affect postoperative events: osteoarthritis, proximal humeral fracture, avascular necrosis, rheumatoid arthritis, nonunion of humeral fracture, rotator cuff arthropathy, or other.
Using ICD-9 codes, the following inhospital adverse events were considered due to their postoperative incidence and effect in orthopedic surgery 18, 19 : 
Statistical Analysis
Multivariate logistic regression models were used to assess the association of epilepsy with predetermined study endpoints: inpatient adverse events, prolonged LOS (>75th percentile for each procedure), 20 and nonroutine discharge (discharged to a location other than home). These models were adjusted for age, sex, race/ethnicity, insurance status, comorbid conditions, primary diagnosis, hospital characteristics, and procedure type to report a multivariate-adjusted odds ratio (OR) with respect to 95% confidence interval (CI). All covariates were entered into the models simultaneously, without further selection.
results
Between January 1, 2002, and December 31, 2011, an estimated total of 422,371 patients underwent shoulder arthroplasty; 3714 (0.9%) had a diagnosis of epilepsy and 418,657 (99.1%) did not (Table) . Baseline characteristics of the cohorts, as well as hospital characteristics of the centers performing the arthroplasty procedures, are shown in the Table. After adjusting for demographics, comorbid conditions, primary diagnosis, hospital characteristics, and procedure type in multivariate modeling (Figure) , epilepsy was associated with the development of postoperative adverse events (OR, 1.68; 95% CI, 1. 
discussion
This study examining the effect of epilepsy on postoperative outcomes after shoulder arthroplasty found that individuals with epilepsy are at greater risk for postoperative morbidity and health care resource use. Risk-adjusted multivariable analysis revealed that patients with a preoperative diagnosis of epilepsy have an increased likelihood of experiencing pneumonia, DVT, gastrointestinal complications, mechanical ventilation, posthemorrhagic anemia, transfusion, prolonged LOS, and nonroutine discharge.
The mechanism by which patients with epilepsy exhibit an increased risk for postoperative complications is most likely multifactorial. Numerous studies demonstrate diverse somatic comorbidities in patients with untreated epilepsy. [21] [22] [23] These subclinical comorbidities may develop into major complications as a result of stress placed on the body during surgery. 3 The authors postulate that many of the postoperative complications experienced disproportionally by patients with epilepsy are due to baseline differences in this population compared with patients without epilepsy.
One such baseline difference that may play a large role in the development of postoperative complications is the use of antiepileptic medications. Antiepileptic medications have been shown to have immunosuppressive and coagulation effects, with carbamazepine, phenytoin, and valproate being considered the highest-risk medications. [24] [25] [26] Medication-induced immunosuppressive and coagulation effects may play a role in the higher incidence of pneumonia, DVT, blood transfusion, and posthemorrhagic anemia seen postopera- 
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Copyright © SLACK inCorporAted n Feature Article tively in patients with epilepsy. 27 Pharmacologically induced immunosuppression may also be the cause of the increased incidence of chronic lung disease and pneumonia seen in patients with epilepsy in general. 21, 24 These known baseline pulmonary abnormalities may explain the high rate of postoperative mechanical ventilation, pneumonia, and prolonged LOS seen in the current study's cohort of patients with epilepsy. The most common coagulation disturbance linked to antiepileptic medication use is thrombocytopenia, which may also explain the increased rate of posthemorrhagic anemia and postoperative transfusion exhibited by this study's cohort of patients with epilepsy. Similarly, thrombocytopenia associated with antiepileptic use may have led operating surgeons to use less anticoagulation in their patients with epilepsy, resulting in the higher rate of DVT seen in the current study's cohort of patients with epilepsy.
Gastrointestinal conditions are also seen as a baseline condition in patients with epilepsy. Individuals with epilepsy are shown to have an increased rate of gastric and intestinal ulcers and bowel disorders at baseline compared with individuals without epilepsy. 28 This baseline increase in gastrointestinal problems may be exacerbated during the stress of shoulder arthroplasty surgery, thus resulting in the elevated rate of postoperative gastrointestinal complications seen in the current study's cohort of patients with epilepsy.
Increased postoperative surveillance with an emphasis on mitigating any possible stressors may be prudent in patients with epilepsy to decrease the risk of postoperative complications following shoulder arthroplasty surgery. This monitoring and intervention should mirror the previously listed baseline abnormalities and directed toward eliminating the postoperative complications identified in this study. Careful consideration should be given to delaying procedures in patients with multiple significant risk factors until modifiable risk factors can be mitigated to optimize postoperative outcomes.
Several important limitations are inherent to the analysis of large administrative databases and should be taken into consideration when interpreting the results of this study. 12, 29 First, the NIS does not provide information about medication use, preventing assessment of patients' antiepileptic therapy and the effect of treatment compliance on outcomes. Second, it is impossible to determine whether diagnoses predate admission or whether they are newly discovered at admission; however, because the diagnosis of epilepsy requires at least 2 unprovoked seizures over time, it is unlikely that this condition would be diagnosed postoperatively, making this limitation less concerning.
Third, the NIS comprises solely inpatient data, resulting in a lack of documentation of post-discharge events, readmissions, and returns to the operating room. This shortcoming makes extrapolation of this study's findings outside of the in-hospital setting unreliable. Fourth, the NIS lacks clinical detail, making it impossible to ascertain the severity of coded complications and diagnoses. Finally, there are concerns of underestimation of diagnoses in any study involving a large health care use database due to documentation errors, coding errors, or conflicting documentation from multiple providers within a patient's medical history. Because the NIS contains no personal identifiers, the authors were not able to validate diagnoses and procedures through cross-referencing medical records 19 ; however, they found an epilepsy prevalence of 0.9% in the study population, which is consistent with current literature estimates of a 0.5% to 1% prevalence of epilepsy in the United States.
conclusion
Despite the shortcomings inherent to data analysis from large health care use databases, this study provides evidence that patients with epilepsy are at higher risk for early postoperative morbidity and resource use following shoulder arthroplasty. These findings should raise awareness of the importance of effective perioperative management of patients with epilepsy undergoing shoulder arthroplasty.
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